BDNF as a promising therapeutic agent in Parkinson's disease

E Palasz, A Wysocka, A Gasiorowska… - International journal of …, 2020 - mdpi.com
Brain-derived neurotrophic factor (BDNF) promotes neuroprotection and neuroregeneration.
In animal models of Parkinson's disease (PD), BDNF enhances the survival of dopaminergic …

Actions of brain-derived neurotrophin factor in the neurogenesis and neuronal function, and its involvement in the pathophysiology of brain diseases

T Numakawa, H Odaka, N Adachi - International journal of molecular …, 2018 - mdpi.com
It is well known that brain-derived neurotrophic factor, BDNF, has an important role in a
variety of neuronal aspects, such as differentiation, maturation, and synaptic function in the …

Mechanisms of α-synuclein induced synaptopathy in Parkinson's disease

JC Bridi, F Hirth - Frontiers in neuroscience, 2018 - frontiersin.org
Parkinson's disease (PD) is characterized by intracellular inclusions of aggregated and
misfolded α-Synuclein (α-Syn), and the loss of dopaminergic (DA) neurons in the brain. The …

Cellular and molecular basis of neurodegeneration in Parkinson disease

XS Zeng, WS Geng, JJ Jia, L Chen… - Frontiers in aging …, 2018 - frontiersin.org
It has been 200 years since Parkinson disease (PD) was described by Dr. Parkinson in
1817. The disease is the second most common neurodegenerative disease characterized …

Preclinical and randomized clinical evaluation of the p38α kinase inhibitor neflamapimod for basal forebrain cholinergic degeneration

Y Jiang, JJ Alam, SN Gomperts, P Maruff… - Nature …, 2022 - nature.com
Abstract The endosome-associated GTPase Rab5 is a central player in the molecular
mechanisms leading to degeneration of basal forebrain cholinergic neurons (BFCN), a long …

The possible role of brain-derived neurotrophic factor in epilepsy

R AlRuwaili, HM Al-Kuraishy, AI Al-Gareeb… - Neurochemical …, 2024 - Springer
Epilepsy is a neurological disease characterized by repeated seizures. Despite of that the
brain-derived neurotrophic factor (BDNF) is implicated in the pathogenesis of …

BDNF/TrkB activators in Parkinson's disease: A new therapeutic strategy

NH Ali, HM Al‐Kuraishy, AI Al‐Gareeb… - Journal of Cellular …, 2024 - Wiley Online Library
Parkinson's disease (PD) is a neurodegenerative disorder of the brain and is manifested by
motor and non‐motor symptoms because of degenerative changes in dopaminergic …

[HTML][HTML] Endosomal dysfunction induced by directly overactivating Rab5 recapitulates prodromal and neurodegenerative features of Alzheimer's disease

A Pensalfini, S Kim, S Subbanna, C Bleiwas… - Cell reports, 2020 - cell.com
Neuronal endosomal dysfunction, the earliest known pathobiology specific to Alzheimer's
disease (AD), is mediated by the aberrant activation of Rab5 triggered by APP-β secretase …

CryoET reveals organelle phenotypes in huntington disease patient iPSC-derived and mouse primary neurons

GH Wu, C Smith-Geater, JG Galaz-Montoya… - Nature …, 2023 - nature.com
Huntington's disease (HD) is caused by an expanded CAG repeat in the huntingtin gene,
yielding a Huntingtin protein with an expanded polyglutamine tract. While experiments with …

[HTML][HTML] LRRK2 inhibition prevents endolysosomal deficits seen in human Parkinson's disease

EM Rocha, BR De Miranda, S Castro, R Drolet… - Neurobiology of …, 2020 - Elsevier
LRRK2 has been implicated in endolysosomal function and likely plays a central role in
idiopathic Parkinson's disease (iPD). In iPD, dopaminergic neurons within the substantia …